Before COVID-19a N (%) | Since COVID-19a N (%) | P value | Total Pricov-19 cohort N (%) | ||
---|---|---|---|---|---|
Before COVID-19 | Since COVID-19 | ||||
Frequency of team meetings to discuss existing, new or amended directives | |||||
Never | 11 (9) | 5 (4.1) | 0.12 | 690 (14.5) | 659 (13.9) |
Weekly or less | 109 (89.3) | 101 (82.1) | 0.21 | 3448 (74.8) | 2926 (61.6) |
Daily | 2 (1.6) | 15 (12.2) | <0.01 | 418 (4.7) | 1000 (21) |
Multiple times per day | 0 | 2 (1.6) | 0.16 | 90 (1) | 168(3.5) |
I have enough protected time for reading guidelines and scientific literature | |||||
(Strongly) agree | 17 (13.9)a | 24 (19.5)b | 0.24 | 1647 (34.2) | 1600 (33.2) |